000839324 000__ 06474cam\a2200529Ii\4500
000839324 001__ 839324
000839324 005__ 20230306144723.0
000839324 006__ m\\\\\o\\d\\\\\\\\
000839324 007__ cr\un\nnnunnun
000839324 008__ 180517s2018\\\\sz\a\\\\o\\\\\001\0\eng\d
000839324 019__ $$a1036238934$$a1037043611$$a1040612288
000839324 020__ $$a9783319786469$$q(electronic book)
000839324 020__ $$a3319786466$$q(electronic book)
000839324 020__ $$z9783319786452
000839324 020__ $$z3319786458
000839324 0247_ $$a10.1007/978-3-319-78646-9$$2doi
000839324 035__ $$aSP(OCoLC)on1035838028
000839324 035__ $$aSP(OCoLC)1035838028$$z(OCoLC)1036238934$$z(OCoLC)1037043611$$z(OCoLC)1040612288
000839324 040__ $$aGW5XE$$beng$$erda$$epn$$cGW5XE$$dN$T$$dEBLCP$$dYDX$$dAZU$$dUAB$$dOCLCF$$dOCLCQ
000839324 049__ $$aISEA
000839324 050_4 $$aRC280.P7
000839324 08204 $$a616.99/463$$223
000839324 24500 $$aProstate cancer :$$bclinical case scenarios /$$cSam S. Chang, Michael S. Cookson, editors.
000839324 264_1 $$aCham, Switzerland :$$bSpringer,$$c2018.
000839324 300__ $$a1 online resource (xiii, 202 pages) :$$billustrations (some color)
000839324 336__ $$atext$$btxt$$2rdacontent
000839324 337__ $$acomputer$$bc$$2rdamedia
000839324 338__ $$aonline resource$$bcr$$2rdacarrier
000839324 347__ $$atext file$$bPDF$$2rda
000839324 500__ $$aIncludes index.
000839324 5050_ $$aIntro; Foreword; Preface; Contents; Contributors; Chapter 1: Prostate Cancer Screening in African-­American Men; Diagnosis and Screening; Evaluation; Management; Conclusion; References; Chapter 2: Evaluation and Treatment for Older Men with Elevated PSA; PSA Screening and USPSTF Recommendations; Impact of USPSTF Recommendations; Overdiagnosis and Overtreatment; Life Expectancy Tools; Assessment of Cancer Risk; Alternatives to PSA-Based Screening: Biomarkers; PSA Derivatives; Free PSA; Prostate Health Index; 4Kscore; Prostate Cancer Antigen 3; Predictive Nomograms; Prostate MRI
000839324 5058_ $$aSpecial Considerations in Elderly PatientsAn Optimized Diagnostic Approach; Conclusions; References; Chapter 3: Utilizing Biomarkers in Patients with Prior Negative Prostate Biopsy; Current Clinical Information; Free PSA; Prostate Health Index; Kallikrein Panel (4Kscore); Prostate Cancer Antigen 3 (PCA3); DNA Methylation Assays (ConfirmMDx); Current Guidelines and Future Directions; Summary; References; Chapter 4: Active Surveillance in African-Americans; Evaluation and Guidelines; Racial Differences in Prostate Cancer Burden and Mortality
000839324 5058_ $$aShould African American Men Be Eligible for Active Surveillance?Considerations for Choosing Active Surveillance; Conclusions; References; Chapter 5: Focal Therapy Versus Surveillance in Intermediate-Risk Cancer; Screening; Diagnosis; Evaluation; Therapeutic Management; Active Surveillance; Focal Therapy; Conclusions; References; Chapter 6: Prostate Cancer Treatment Options for Men with Significant Urinary Symptoms and Enlarged Prostates; Evaluation; Therapeutic Management; Conclusion; References; Chapter 7: Adjuvant Radiation Therapy for High-­Risk Post-prostatectomy Patients
000839324 5058_ $$aPre-prostatectomy Patient EvaluationPost-prostatectomy Patient Evaluation; Post-prostatectomy Radiation Therapy; Adjuvant Radiation Therapy; Salvage Radiation Therapy; Selective Treatment Intensification with Post-prostatectomy Radiation Therapy; Future Directions; Conclusions and Recommendations for Presented Clinical Case; References; Chapter 8: Biochemical Recurrence After Radiation Therapy; Screening/Surveillance; Recurrence Risk; Concurrent Androgen Deprivation Therapy; PSA Kinetics; Disease-Specific Risk; Surveillance Schedule; Diagnosis; Variation Between Radiation and Surgery
000839324 5058_ $$aBenign Prostate TissuePSA Bounce; Biochemical Recurrence Definition; Historical/Alternative Criteria; Phoenix Criteria; Evaluation; Sites of Recurrence; Traditional Evaluation; Imaging Evaluation; Bone Imaging; CT Scan/MRI; Role of Biopsy; Emerging/Advanced Imaging; Therapeutic Management; Localized Salvage Treatment; Considerations; Observation; Salvage Prostatectomy; Salvage Radiation; Salvage Cryoablation; Salvage HIFU; Distant Salvage Treatment; Treatment of Oligometastatic Disease with Radiation or Surgical Excision; Systemic Treatment Options; Androgen Deprivation Therapy; Conclusion
000839324 506__ $$aAccess limited to authorized users.
000839324 520__ $$aThis book provides a single, comprehensive reference source that incorporates all the latest information regarding prostate cancer. It serves as an easy reference source for researchers, clinicians, individuals in training, allied health professionals and medical students regarding prostate cancer by focusing on the controversial points of debate. New data regarding PSA screening, prostate cancer biomarkers, diagnostic evaluation techniques, surveillance protocols, and treatment interventions for localized and more advanced disease are discussed, and gaps in current knowledge and areas for future research are highlighted. Ongoing important clinical trials are also discussed. This text is organized around defined clinical scenarios which are encountered routinely by physicians who care for patients with prostate cancer. The case based format permits presentation of information of concise practical significance. The chapters run the gamut from screening controversies, utility of biomarkers, surveillance strategies, and innovative treatment. The text incorporates key educational concepts in the framework of patient situations with evidence-based discussions of screening, diagnosis, evaluation, and therapeutic management. It also features a comment section from leaders in the field that will be more "opinion-based" allowing the reader to get access to experienced physicians' thought processes and practice patterns. Prostate Cancer: Clinical Case Scenarios will quickly become the ready reference source for professionals and students in various fields with an interest in the management of a complex and multifaceted disease such as prostate cancer.
000839324 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed May 17, 2018).
000839324 650_0 $$aProstate$$xCancer$$xDiagnosis$$vCase studies.
000839324 650_0 $$aProstate$$xCancer$$xTreatment$$vCase studies.
000839324 7001_ $$aChang, Sam S.$$c(Urologist),$$eeditor.
000839324 7001_ $$aCookson, Michael S.$$eeditor.
000839324 77608 $$iPrint version: $$z3319786458$$z9783319786452$$w(OCoLC)1027134110
000839324 852__ $$bebk
000839324 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-78646-9$$zOnline Access$$91397441.1
000839324 909CO $$ooai:library.usi.edu:839324$$pGLOBAL_SET
000839324 980__ $$aEBOOK
000839324 980__ $$aBIB
000839324 982__ $$aEbook
000839324 983__ $$aOnline
000839324 994__ $$a92$$bISE